BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25918047)

  • 21. N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk.
    Wijsman LW; Sabayan B; van Vliet P; Trompet S; de Ruijter W; Poortvliet RK; van Peet PG; Gussekloo J; Jukema JW; Stott DJ; Sattar N; Ford I; Westendorp RG; de Craen AJ; Mooijaart SP
    Ann Neurol; 2014 Aug; 76(2):213-22. PubMed ID: 24942833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
    Everett BM; Ridker PM; Cook NR; Pradhan AD
    Am J Cardiol; 2015 Aug; 116(4):532-7. PubMed ID: 26081066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults.
    Daniels LB; Laughlin GA; Kritz-Silverstein D; Clopton P; Chen WC; Maisel AS; Barrett-Connor E
    Am J Med; 2011 Jul; 124(7):670.e1-8. PubMed ID: 21683832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
    Rutten JH; Mattace-Raso FU; Steyerberg EW; Lindemans J; Hofman A; Wieberdink RG; Breteler MM; Witteman JC; van den Meiracker AH
    Hypertension; 2010 Mar; 55(3):785-91. PubMed ID: 20083731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
    Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R; Allison MA; Criqui MH
    J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
    J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study.
    Echouffo-Tcheugui JB; Zhang S; Daya N; McEvoy JW; Tang O; Juraschek SP; Ndumele CE; Coresh J; Christenson RH; Selvin E
    J Am Heart Assoc; 2023 Jun; 12(11):e029110. PubMed ID: 37232235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BNP and NT-proBNP, predictors of 1-year mortality in nursing home residents.
    Barents M; Hillege HH; van der Horst IC; de Boer RA; Koster J; Muskiet FA; de Jongste MJ
    J Am Med Dir Assoc; 2008 Oct; 9(8):580-5. PubMed ID: 19083292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
    Welsh P; Doolin O; Willeit P; Packard C; Macfarlane P; Cobbe S; Gudnason V; Di Angelantonio E; Ford I; Sattar N
    Eur Heart J; 2013 Feb; 34(6):443-50. PubMed ID: 22942340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
    Rudman M; Frank M; Emmel C; Matusch E; Kara K; Mahabadi AA; Erbel R; Jöckel KH; Dragano N; Schmidt B
    PLoS One; 2021; 16(8):e0255786. PubMed ID: 34415953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women.
    Everett BM; Berger JS; Manson JE; Ridker PM; Cook NR
    J Am Coll Cardiol; 2014 Oct; 64(17):1789-97. PubMed ID: 25443700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
    Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NT-proBNP and the risk of dementia: a prospective cohort study with 14 years of follow-up.
    Tynkkynen J; Laatikainen T; Salomaa V; Havulinna AS; Blankenberg S; Zeller T; Hernesniemi JA
    J Alzheimers Dis; 2015; 44(3):1007-13. PubMed ID: 25408211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.